Form 4: NovoCure COO Sells Shares to Cover Tax Obligations
SEC Form 4
NovoCure's Chief Operating Officer, Mukund Paravasthu, sold 160 ordinary shares to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- On November 1, 2024, Mukund Paravasthu, the Chief Operating Officer of NovoCure Ltd, sold 160 ordinary shares of the company.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- The shares were sold at a weighted average price of $15.8776, with individual trades ranging from $15.80 to $15.94.
- Following the transaction, Paravasthu directly owns 3,503 ordinary shares.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (sell to cover taxes) and doesn't indicate any significant positive or negative sentiment. It's a neutral event.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 2024-10-01 | Date of execution for the Limited Power of Attorney. |
| 2024-11-01 | Date of the transaction: sale of 160 ordinary shares. |
| 2024-11-04 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.